Pramirol 0.5 Tablet
By Pramirol
Rx
10 Tablet in a Strip

Composition
Pramipexole(0.5mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
November, 2027

liver
For individuals with liver disease, using Pramirol 0.5 Tablet is considered safe. The available data indicates that adjusting the dosage of Pramirol 0.5 Tablet may not be necessary for patients with liver conditions. It is advisable to consult with your doctor about using this medication. In cases of liver impairment, dose adjustment may be necessary. If you have liver impairment or any concerns about your liver health, it is important to consult your doctor before using Pramirol 0.5 Tablet.

kidney
Pramirol 0.5 Tablet should be used carefully if you have kidney disease. Adjustment of the dose may be required. Consult your doctor for guidance.

alcohol
When taking Pramirol 0.5 Tablet, avoid alcohol to prevent excessive drowsiness and increased dizziness.

driving
Pramirol 0.5 Tablet may cause hallucinations, affecting driving ability. Side effects like dizziness and sleepiness may also occur, impacting focus. Avoid driving or using machinery if experiencing these symptoms.

pregnancy
Pramirol 0.5 Tablet may not be safe during pregnancy. Animal studies suggest harm to the developing baby. Your doctor will assess benefits and risks before prescribing. Please consult your doctor for any concerns; benefits must outweigh risks for prescription.

breastfeeding
Pramirol 0.5 Tablet is not recommended while breastfeeding as it may pass into breastmilk, affecting the baby and suppressing serum prolactin production. If unavoidable, stop breastfeeding and consult a doctor.
Habit Forming | No |
Chemical Class | Benzothiazole Derivative |
Therapeutic Class | NEURO CNS |
Action Class | Dopamine agonists |
₹202
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024